Search - tctmd.com

Displaying 1 - 20 of 81

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2025

Are Bioresorbable Scaffolds Making a Comeback?

Presenter: Ajay Kirtane

November 13, 2025

Presentation TCT Abstracts Posters 2018

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

Presenter: Cigdem Koca Tari

September 25, 2018

Presentation ESC 2018

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

Presenter: Holger M. Nef

August 29, 2018

Presentation ACC 2018

Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Presenter: Ajay J. Kirtane

March 11, 2018

Presentation EuroPCR 2017

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Presenter: Runlin Gao

May 17, 2017

Presentation SCAI 2017

Long-term outcomes of Bioresorbable Vascular Scaffolds

Presenter: Roxana Mehran

May 13, 2017

Presentation ACC 2017

Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results

Presenter: Stephen G. Ellis

March 19, 2017

Presentation JIM 2017

Bioresorbable Scaffolds is a Real Need:CONTRA

Presenter: Robert A. Byrne

February 10, 2017

Presentation JIM 2017

Bioresorbable Scaffolds: A Real Clinical Need? Yes!

Presenter: Gregg W. Stone

February 10, 2017

Presentation JIM 2017

Bioresorbable Scaffolds: An Important Clinical Need

Presenter: Gregg W. Stone

February 08, 2017

Presentation TCT 2016

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso

November 02, 2016

Presentation SOLACI 2016

Complex PCI with BioResorbable Scaffolds

Presenter: Cristiano Guedes

June 09, 2016

Presentation

Outcomes with Bioresorbable Vascular Scaffolds versus Everolimus-Eluting Stent

Presenter: Sripal Bangalore

March 29, 2016

Presentation JIM 2016

Bioresorbable Vascular Scaffolds for Chronic Total Occlusions: Clinical and Multi-imaging follow-up Outcomes

Presenter: Antonio Serra

February 10, 2016

Presentation JIM 2016

Bioresorbable Vascular Scaffolds: Clinical Updates and Case Reviews

Presenter: Antonio L. Bartorelli

February 09, 2016

Presentation

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Presenter: Jens Wiebe

August 26, 2015

Presentation BRS 2015

BIORESORBABLE VASCULAR SCAFFOLDS A One-day Case-based Technique-oriented Course: A Case with Vessel and - or Lesion Tortuosity

Presenter: Antonio L. Bartorelli

February 10, 2015

Presentation

Beyond the Early Stages: Insights from the ASSURE Registry on Bioresorbable Vascular Scaffolds

Presenter: J. W?hrle

December 21, 2014

Presentation TCT 2014

Con: The Psychological Attraction Will Pass When the Data Emerges!

Presenter: Daniel I. Simon

September 16, 2014

Presentation TCT 2014

Pro: Within 10 Years, Most Coronary Intervention Will Use BRS!

Presenter: Stephan Achenbach

September 16, 2014

Advertisement

Are Bioresorbable Scaffolds Making a Comeback?

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Long-term outcomes of Bioresorbable Vascular Scaffolds

Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results

Bioresorbable Scaffolds is a Real Need:CONTRA

Bioresorbable Scaffolds: A Real Clinical Need? Yes!

Bioresorbable Scaffolds: An Important Clinical Need

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Complex PCI with BioResorbable Scaffolds

Outcomes with Bioresorbable Vascular Scaffolds versus Everolimus-Eluting Stent

Bioresorbable Vascular Scaffolds for Chronic Total Occlusions: Clinical and Multi-imaging follow-up Outcomes

Bioresorbable Vascular Scaffolds: Clinical Updates and Case Reviews

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

BIORESORBABLE VASCULAR SCAFFOLDS A One-day Case-based Technique-oriented Course: A Case with Vessel and - or Lesion Tortuosity

Beyond the Early Stages: Insights from the ASSURE Registry on Bioresorbable Vascular Scaffolds

Con: The Psychological Attraction Will Pass When the Data Emerges!

Pro: Within 10 Years, Most Coronary Intervention Will Use BRS!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content